132 related articles for article (PubMed ID: 31455274)
1. Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.
Wu L; Zheng K; Yan C; Pan X; Liu Y; Liu J; Wang F; Guo W; He X; Li J; Shen Y
BMC Cancer; 2019 Aug; 19(1):843. PubMed ID: 31455274
[TBL] [Abstract][Full Text] [Related]
2. Genomewide Study of Salivary MicroRNAs for Detection of Oral Cancer.
Momen-Heravi F; Trachtenberg AJ; Kuo WP; Cheng YS
J Dent Res; 2014 Jul; 93(7 Suppl):86S-93S. PubMed ID: 24718111
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1).
Song H; Wang Q; Guo Y; Liu S; Song R; Gao X; Dai L; Li B; Zhang D; Cheng J
BMC Infect Dis; 2013 Jun; 13():257. PubMed ID: 23731466
[TBL] [Abstract][Full Text] [Related]
4. Candidate pathways and genes for nasopharyngeal carcinoma based on bioinformatics study.
Chen J; Yang R; Zhang W; Wang Y
Int J Clin Exp Pathol; 2015; 8(2):2026-32. PubMed ID: 25973099
[TBL] [Abstract][Full Text] [Related]
5. Combination of RERG and ZNF671 methylation rates in circulating cell-free DNA: A novel biomarker for screening of nasopharyngeal carcinoma.
Xu Y; Zhao W; Mo Y; Ma N; Midorikawa K; Kobayashi H; Hiraku Y; Oikawa S; Zhang Z; Huang G; Takeuchi K; Murata M
Cancer Sci; 2020 Jul; 111(7):2536-2545. PubMed ID: 32324312
[TBL] [Abstract][Full Text] [Related]
6. Salivary Small Extracellular Vesicles Associated miRNAs in Periodontal Status-A Pilot Study.
Han P; Bartold PM; Salomon C; Ivanovski S
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316600
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Transcriptomics Profiling of MicroRNA Reveals Plasma Circulating Biomarkers of Hypertrophic Cardiomyopathy and Dysregulated Signaling Pathways.
Liang LW; Hasegawa K; Maurer MS; Reilly MP; Fifer MA; Shimada YJ
Circ Heart Fail; 2023 Jun; 16(6):e010010. PubMed ID: 37305994
[TBL] [Abstract][Full Text] [Related]
8. Identification of microRNA as sepsis biomarker based on miRNAs regulatory network analysis.
Huang J; Sun Z; Yan W; Zhu Y; Lin Y; Chen J; Shen B; Wang J
Biomed Res Int; 2014; 2014():594350. PubMed ID: 24809055
[TBL] [Abstract][Full Text] [Related]
9. MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.
Chen Y; Lin T; Tang L; He L; He Y
Am J Cancer Res; 2023; 13(12):5805-5824. PubMed ID: 38187072
[TBL] [Abstract][Full Text] [Related]
10. Salivary miRNAs as auxiliary liquid biopsy biomarkers for diagnosis in patients with oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis.
Nguyen H; Nonaka T
Front Genet; 2024; 15():1352838. PubMed ID: 38528913
[No Abstract] [Full Text] [Related]
11. Salivary MicroRNA for Diagnosis of Cancer and Systemic Diseases: A Systematic Review.
Setti G; Pezzi ME; Viani MV; Pertinhez TA; Cassi D; Magnoni C; Bellini P; Musolino A; Vescovi P; Meleti M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019170
[TBL] [Abstract][Full Text] [Related]
12. Sources to variability in circulating human miRNA signatures.
Keller A; Rounge T; Backes C; Ludwig N; Gislefoss R; Leidinger P; Langseth H; Meese E
RNA Biol; 2017 Dec; 14(12):1791-1798. PubMed ID: 28820329
[TBL] [Abstract][Full Text] [Related]
13. Stability of circulating miRNA in saliva: The influence of sample associated pre-analytical variables.
Romani C; Baronchelli M; Assoni C; Mattavelli D; Calza S; Piazza C; Bossi P
Clin Chim Acta; 2024 Jan; 553():117702. PubMed ID: 38097127
[TBL] [Abstract][Full Text] [Related]
14. Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data.
Tran C; Dinh P
J Biomol Struct Dyn; 2024 Mar; ():1-14. PubMed ID: 38487855
[TBL] [Abstract][Full Text] [Related]
15. Validation of a Salivary miRNA Signature of Endometriosis - Interim Data.
Bendifallah S; Dabi Y; Suisse S; Delbos L; Spiers A; Poilblanc M; Golfier F; Jornea L; Bouteiller D; Fernandez H; Madar A; Petit E; Perotte F; Fauvet R; Benjoar M; Akladios C; Lavoué V; Darnaud T; Merlot B; Roman H; Touboul C; Descamps P
NEJM Evid; 2023 Jul; 2(7):EVIDoa2200282. PubMed ID: 38320163
[TBL] [Abstract][Full Text] [Related]
16. Preanalytic Methodological Considerations and Sample Quality Control of Circulating miRNAs.
Chan SF; Cheng H; Goh KK; Zou R
J Mol Diagn; 2023 Jul; 25(7):438-453. PubMed ID: 37030398
[TBL] [Abstract][Full Text] [Related]
17. Peripheral blood MicroRNAs as biomarkers of schizophrenia: expectations from a meta-analysis that combines deep learning methods.
Han S; Li Y; Gao J
World J Biol Psychiatry; 2024; 25(1):65-81. PubMed ID: 37703215
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
19. The roles and implications of RNA m
Deng X; Qing Y; Horne D; Huang H; Chen J
Nat Rev Clin Oncol; 2023 Aug; 20(8):507-526. PubMed ID: 37221357
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
